ANTX AN2 Therapeutics Inc

USD 1.04 0.02 ( 1.960784)
Icon

AN2 Therapeutics Inc (ANTX) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 1.04

+0.02 (+1.96)%

USD 0.03B

0.25M

USD 3.00(+188.46%)

N/A

Icon

ANTX

AN2 Therapeutics Inc (USD)
COMMON STOCK | NSD
USD 1.04
0.02 ( 1.960784)

AN2 Therapeutics Inc (ANTX) Stock Forecast

Show ratings and price targets of :
USD 3.00
(+188.46%)

Based on the AN2 Therapeutics Inc stock forecast from 3 analysts, the average analyst target price for AN2 Therapeutics Inc is USD 3.00 over the next 12 months. AN2 Therapeutics Inc’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of AN2 Therapeutics Inc is Bearish, which is based on 1 positive signals and 5 negative signals. At the last closing, AN2 Therapeutics Inc’s stock price was USD 1.04. AN2 Therapeutics Inc’s stock price has changed by -7.96% over the past week, +0.97% over the past month and -93.33% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...